Commure Pursues Hospital Software Roll-Up

This target shows that Commure is no longer trying to grow like a single product software company, it is assembling hospital revenue in chunks. The fast path comes from layering Athelas' billing and remote monitoring products onto provider groups, then adding acquired lines like Augmedix, whose $139M sale gave Commure an immediate ambient documentation business and deeper access to large health system workflows.

• The base was already moving quickly. Estimated ARR rose from $60M at year end 2023 to $104M in March 2024, after the Athelas merger expanded Commure from enterprise hospital software into revenue cycle management and remote patient monitoring sold to thousands of providers.
  1 sacra 2 sacra
• The organic piece is mostly cross sell, not simple seat growth. Hospitals buy fixed fee contracts, so expansion comes from selling another workflow, such as documentation, billing, patient messaging, or monitoring, into an account that already uses one Commure product.
  3 sacra 4 augmedix
• The acquisition piece is about buying products that already sit inside clinician workflows. Augmedix adds medical note creation during visits, and Commure's HCA deal shows how that documentation layer can open the door to broader AI tools across a major health system network.
  3 sacra 4 augmedix 5 commure

Going forward, Commure is heading toward a roll up model for hospital software, where growth comes from owning more of the daily work around a patient visit. If integration holds, each added product makes Commure harder to rip out and pushes it closer to a credible all in one alternative around the EHR.